Growth hormone axis

CJC-1295 and ipamorelin blends pair two unapproved growth hormone peptides. No study has tested the mix, and FDA records show sterility recalls.

IGF-1 DES is a shortened IGF-1 studied in cells and rats. Muscle and fat claims checked, why it has never been tested in people, and its risks.

Macimorelin (Macrilen) is an FDA approved oral test for adult growth hormone deficiency. It is a one time diagnostic, not a treatment.

Anamorelin (Adlumiz) is approved in Japan for cancer cachexia. Trials show small weight and muscle gains but no strength gain. Not FDA approved.

Follistatin and follistatin 344 explained: muscle and strength claims checked, animal results, tiny gene therapy trials, and the risks.

GHRP-2 (pralmorelin): what human studies show on growth hormone, hunger, growth in children and recovery, plus FDA safety concerns and WADA status.

GHRP-6 explained: what small human studies show on growth hormone and sleep, animal heart results, FDA safety concerns and its WADA ban.

IGF-1 LR3 explained: muscle and fat claims checked against the evidence, how it differs from approved mecasermin, and its low blood sugar risk.